CLEVELAND–(BUSINESS WIRE)–$ATHX–Athersys, Inc. (Nasdaq: ATHX) today announced that its equity purchase agreement with Aspire Capital Fund LLC (Aspire Capital) has been terminated. The Company continues to evaluate alternative financing options to support continuing operations. After several discussions with Aspire Capital, Athersys received notice on July 6, 2022 of termination of the equity purchase agreement, effective … [Read more…]
CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces that Gaurav Shah, M.D., Chief Executive Officer, will participate in a fireside chat at the William Blair Biotech Focus Conference 2022 on July … [Read more…]
Changes expected to have positive impact on 2023 earnings Company ending its participation in the BPCI-A program to focus on supporting future growth DALLAS & NEW YORK–(BUSINESS WIRE)–Signify Health, Inc. (NYSE: SGFY) today announced that it is winding down its Episodes of Care Services (ECS) segment in order to focus on its fast-growing and profitable … [Read more…]
LONDON–(BUSINESS WIRE)–On July 7, 2022, invoX Pharma Limited (“invoX”), a wholly owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) commenced a cash tender offer for all of the issued and outstanding shares of common stock of F-star Therapeutics, Inc. (“F-star”) (NASDAQ:FSTX) for a price of $7.12 per share. The tender offer is … [Read more…]
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases today announced that the compensation committee of Aerie Pharmaceutical’s board of directors granted one new employee an award totaling 16,900 stock … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Beauty Drinks Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global beauty drinks market reached a value of US$ 1.5 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 2.8 Billion by 2027, exhibiting a … [Read more…]
DUESSELDORF, Germany–(BUSINESS WIRE)–DxPx Conference US – for the first time in person in the US! The three-day partnering conference is taking place from July 26th to 28th, 2022 at the AACC Clinical Lab Expo in McCormick Place, Chicago. DxPx Conference US 2021 took place virtually due to the pandemic, and this year DxPx is taking … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Non-Cystic Fibrosis Bronchiectasis (NCFB) – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Non-Cystic Fibrosis Bronchiectasis (NCFB)- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Non-Cystic Fibrosis Bronchiectasis (NCFB), historical and forecasted epidemiology as well as the Non-Cystic Fibrosis Bronchiectasis (NCFB) … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Alpha-Antitrypsin Deficiency – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. The Alpha-Antitrypsin Deficiency market report provides current treatment practices, emerging drugs, Alpha- Antitrypsin Deficiency market share of the individual therapies, current and forecasted Alpha- Antitrypsin Deficiency market Size from 2019 to 2032 segmented by seven major … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Allergic Rhinitis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Allergic Rhinitis- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Allergic Rhinitis, historical and forecasted epidemiology as well as the Allergic Rhinitis market trends in the United States, EU5 (Germany, … [Read more…]
